Influence of chemotherapeutic agents on the antibacterial activity of normal and leukemic sera.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001770:Blood Bactericidal Activity / Q000187:drug effects*; D002330:Carmustine / Q000494:pharmacology; D002462:Cell Membrane; D003165:Complement System Proteins / Q000032:analysis; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage / Q000494:pharmacology; D003630:Daunorubicin / Q000008:administration & dosage / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004926:Escherichia coli; D005472:Fluorouracil / Q000494:pharmacology; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007938:Leukemia / Q000188:drug therapy; D008466:Mechlorethamine / Q000008:administration & dosage / Q000494:pharmacology; D008727:Methotrexate / Q000008:administration & dosage / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009113:Muramidase / Q000032:analysis; D011241:Prednisone / Q000494:pharmacology; D014750:Vincristine / Q000494:pharmacology
D000970:Antineoplastic Agents; D007136:Immunoglobulins; D003561:Cytarabine; D008466:Mechlorethamine; D014750:Vincristine; D003520:Cyclophosphamide; D003165:Complement System Proteins; D009113:Muramidase; D005472:Fluorouracil; D002330:Carmustine; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin